During the past decade, Centre for Eye Research Australia conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 5 clinical trials were completed, i.e. on average, 14.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 5 clinical trials were completed. i.e. 20.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre for Eye Research Australia" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Center for Eye Research Australia" with 5 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "ONL Therapeutics" with 3 trials sponsored and "University of Melbourne" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Eye Research Australia" #1 collaborator was "Clinical Vision Research Australia" with 3 trials as a collaborator, "Novartis Pharmaceuticals" with 3 trials as a collaborator, "Centre for Eye Research Australia" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator and "Novotech (Australia) Pty Limited" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Eye Research Australia" are "Geographic Atrophy" (5 trials), "Diabetic Retinopathy" (4 trials), "Diabetic Macular Edema" (3 trials), "Macular Degeneration" (3 trials) and "Macular Edema" (3 trials). Many other conditions were trialed in "Centre for Eye Research Australia" in a lesser frequency.

Most popular intervention types in "Centre for Eye Research Australia" are "Drug" (26 trials), "Device" (11 trials), "Other" (9 trials), "Procedure" (9 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Faricimab" (6 trials), "Aflibercept" (5 trials), "Ranibizumab" (2 trials) and "Silicone hydrogel contact lens" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Eye Research Australia" are 40 trials for "All" genders.

Currently, there are NaN active trials in "Centre for Eye Research Australia". undefined are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Centre for Eye Research Australia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Eye Research Australia, 7 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".